| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 52,3 k € | +388.6% | 10,7 k € | -27.6% | 14,8 k € | -35.4% | 22,9 k € | +14.0% | 20,1 k € | -17.4% | 24,3 k € | -30.0% | 34,7 k € | +32.2% | 26,3 k € | +75.2% | 15,0 k € | -31.4% | 21,9 k € | +51.2% | 14,5 k € | +86.2% | 7,8 k € | -11.7% | 8,8 k € | -44.4% | 15,8 k € | -24.3% | 20,9 k € | +17.6% | 17,8 k € | +31.0% | 13,6 k € | -16.4% | 16,2 k € | -34.1% | 24,7 k € | +14.8% | 21,5 k € | |
| EBITDA | 51,5 k € | +422.5% | 9,8 k € | -28.4% | 13,8 k € | -36.9% | 21,8 k € | +13.2% | 19,3 k € | -17.9% | 23,4 k € | -30.6% | 33,8 k € | +33.5% | 25,3 k € | +83.3% | 13,8 k € | -34.0% | 20,9 k € | +55.1% | 13,5 k € | +103.0% | 6,6 k € | -13.5% | 7,7 k € | -48.4% | 14,9 k € | -25.1% | 19,9 k € | +21.1% | 16,4 k € | +32.0% | 12,4 k € | -18.4% | 15,3 k € | -35.4% | 23,6 k € | +17.6% | 20,1 k € | |
| Operating profit | 42,1 k € | +3406.1% | 1,2 k € | -82.3% | 6,8 k € | -20.1% | 8,5 k € | +18.1% | 7,2 k € | -37.3% | 11,4 k € | -43.9% | 20,4 k € | +83.9% | 11,1 k € | +45.5% | 7,6 k € | -50.8% | 15,5 k € | +387.6% | 3,2 k € | +370.8% | -1,2 k € | -1.3% | -1,2 k € | -118.8% | 6,2 k € | -44.8% | 11,2 k € | -7.4% | 12,1 k € | +50.8% | 8,0 k € | +30.0% | 6,2 k € | -9.8% | 6,8 k € | +128.1% | 3,0 k € | |
| Profit/loss | 27,8 k € | +8790.9% | 313,1 € | -90.9% | 3,4 k € | -42.2% | 6,0 k € | +35.4% | 4,4 k € | -45.4% | 8,1 k € | -50.0% | 16,1 k € | +115.5% | 7,5 k € | +33.4% | 5,6 k € | -51.0% | 11,4 k € | +199.2% | 3,8 k € | +343.1% | -1,6 k € | -8.8% | -1,4 k € | -132.7% | 4,4 k € | -48.6% | 8,6 k € | -9.8% | 9,5 k € | +35.5% | 7,0 k € | +44.2% | 4,9 k € | -6.2% | 5,2 k € | +212.8% | 1,7 k € | |
| Equity | 49,9 k € | +25.1% | 39,9 k € | -26.9% | 54,6 k € | -6.1% | 58,2 k € | +11.4% | 52,2 k € | +9.2% | 47,8 k € | -0.9% | 48,2 k € | +14.5% | 42,1 k € | -58.7% | 102,1 k € | +5.8% | 96,5 k € | +12.4% | 85,9 k € | +3.6% | 82,9 k € | -2.8% | 85,3 k € | -10.3% | 95,0 k € | +3.9% | 91,4 k € | +9.3% | 83,6 k € | +11.6% | 74,9 k € | +9.0% | 68,7 k € | +6.3% | 64,6 k € | +8.7% | 59,4 k € | |
| Total assets | 85,8 k € | +12.5% | 76,3 k € | -7.7% | 82,7 k € | +20.0% | 68,9 k € | +6.6% | 64,7 k € | -1.7% | 65,8 k € | -6.9% | 70,6 k € | -18.3% | 86,4 k € | -21.5% | 110,0 k € | +0.9% | 109,1 k € | +11.4% | 97,9 k € | +13.8% | 86,1 k € | -9.5% | 95,1 k € | -14.7% | 111,4 k € | -1.7% | 113,4 k € | +27.7% | 88,8 k € | +6.6% | 83,3 k € | +9.5% | 76,1 k € | -4.7% | 79,8 k € | -0.9% | 80,5 k € | |
| Cash | 60,3 k € | +34.3% | 44,9 k € | -1.5% | 45,5 k € | +10.5% | 41,2 k € | +10.4% | 37,3 k € | +15.2% | 32,4 k € | +38.4% | 23,4 k € | -18.9% | 28,9 k € | -60.1% | 72,4 k € | -5.9% | 76,9 k € | +18.8% | 64,7 k € | +10.7% | 58,5 k € | -9.9% | 65,0 k € | -17.1% | 78,4 k € | +3.8% | 75,5 k € | +9.5% | 68,9 k € | +9.7% | 62,9 k € | +3.5% | 60,7 k € | +1.9% | 59,6 k € | +29.7% | 45,9 k € | |
| Debts | 35,9 k € | -1.4% | 36,4 k € | +29.4% | 28,1 k € | +160.9% | 10,8 k € | -13.6% | 12,5 k € | -30.5% | 18,0 k € | -19.7% | 22,4 k € | -49.4% | 44,3 k € | +461.6% | 7,9 k € | -37.1% | 12,5 k € | +4.6% | 12,0 k € | +285.1% | 3,1 k € | -68.2% | 9,8 k € | -40.2% | 16,4 k € | -25.4% | 22,0 k € | +326.9% | 5,1 k € | -38.5% | 8,4 k € | +13.6% | 7,4 k € | -51.6% | 15,2 k € | -27.9% | 21,1 k € | |
Private limited company · Fleurus · incorporated on 26/02/1998
Private limited company profitable and well capitalised. Cash position rising (+34.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DEGSA KINE is a Private limited company incorporated in 1998. Its main activity is: Other human health activities. Its registered office is in Fleurus.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette